Aromatase inhibitors for the treatment of infertility
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Ovarian stimulation during infertility treatment is used either alone or in conjunction with intrauterine insemination and assisted reproductive technologies. At the present time, the two main medications used for ovarian stimulation include an oral antioestrogen, clomiphene citrate and injectable gonadotrophins. In spite of the high ovulation rate, the use of clomiphene citrate is associated with adverse side effects and low pregnancy rates. In clomiphene citrate failures, gonadotrophin injections are generally the next treatment option but, especially in polycystic ovarian syndrome, are associated with increased risk of severe ovarian hyperstimulation syndrome and high multiple pregnancies. Therefore, an effective oral treatment that could be used without risk of ovarian hyperstimulation syndrome and with minimal monitoring is preferred. It was hypothesised that aromatase inhibitors can be administered early in the follicular phase to induce ovulation by releasing the hypothalamus and/or pituitary from oestrogen negative feedback. The success of aromatase inhibitors in induction and augmentation of ovulation has been reported. In addition, increased intraovarian androgen levels may synergise with central effects of decreased oestrogen to enhance ovarian response to gonadotrophin stimulation. This increased sensitivity to follicle-stimulating hormone may be especially useful in poor responders. The potential future applications for aromatase inhibitors in infertility management are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Population study of causes, treatment, and outcome of infertility.
Hull, M. G., Glazener, C. M., Kelly, N. J., Conway, D. I., Foster, P. A., Hinton, R. A., Coulson, C., Lambert, P. A., Watt, E. M., & Desai, K. M. (1985) · BMJ · doi:10.1136/bmj.291.6510.1693 · Cited by 1,141 · cited 1×
“About 15% of couples will have more than one cause for their infertility [5-7].”
BackgroundMitwally, M. F. M., & Casper, R. F. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01705-2 · Cited by 800 · cited 4×
“The success of aromatase inhibition in inducing and augmenting ovulation encouraged us to try an aromatase inhibitor in cases of CC failure and we were successful in achieving ovulation and pregnancy [93,94].”
BackgroundInfluentialSelf-citationAndrogens stimulate early stages of follicular growth in the primate ovary
Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J., & Bondy, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2081 · Cited by 712 · cited 4×
“We reported the success of an aromatase inhibitor for augmenting ovulation in patients with ovulatory infertility, for example, unexplained infertility, endometriosis, women undergoing therapeutic donor insemination and in ovulating partners of infertile men [83-84].”
BackgroundInfluentialAndrogen and follicle stimulating hormone interactions in primate ovarian follicle development
Weil, S., Vendola, K., Zhou, J., & Bondy, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5929 · Cited by 592
Ehrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., & Polonsky, K. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4069 · Cited by 461
Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders
Mitwally, M. F. M., & Casper, R. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03280-0 · Cited by 407
Self-citationBuzdar, A., Jonat, W., Howell, A., Jones, S. E., Blomqvist, C., Vogel, C. L., Eiermann, W., Wolter, J. M., Azab, M., Webster, A., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2000 · Cited by 406
Endocrine treatment of breast cancer in women
SANTEN, R. J., MANNI, A., HARVEY, H., & REDMOND, C. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-221 · Cited by 399 · cited 1×
“The main sources of circulating oestrogens are the ovaries in premenopausal women and adipose tissue in postmenopausal women [53,54].”
Background17α-Hydroxylase/17,20 lyase deficiency: from clinical investigation to molecular definition
YANASE, T., SIMPSON, E. R., & WATERMAN, M. R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-1-91 · Cited by 390
AROMATASE INHIBITORS FOR MALE INFERTILITY
Raman, J. D., & Schlegel, P. N. (2002) · Journal of Urology · doi:10.1016/s0022-5347(01)69099-2 · Cited by 383
Conte, F. A., Grumbach, M. M., Ito, Y., Fisher, C. R., & Simpson, E. R. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.8200927 · Cited by 379
Weil, S. J., Vendola, K., Zhou, J., Adesanya, O. O., Wang, J., Okafor, J., & Bondy, C. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4917 · Cited by 359 · cited 3×
“There was an inverse relationship between oestradiol and LH levels until later in the follicular phase when rising levels of oestradiol stimulated the LH surge [82].”
BackgroundInfluentialVendola, K., Zhou, J., Wang, J., Famuyiwa, O. A., Bievre, M., & Bondy, C. A. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.2.353 · Cited by 324
Mechanism and inhibition of cytochrome P-450 aromatase
Cole, P. A., & Robinson, C. H. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00173a001 · Cited by 319 · cited 1×
“Aromatase is a microsomal member of the cytochrome P450 haemoprotein-containing enzyme complex superfamily (P450arom, the product of the CYP19 gene) that catalyses the rate-limiting step in the production of oestrogens, that is, the conversion of androstenedione and testosterone via three hydroxylation steps to estron…”
BackgroundEffect of estrogen deprivation on the reproductive physiology of male and female primates
Shetty, G., Krishnamurthy, H., Krishnamurthy, H. N., Bhatnagar, A. S., & Moudgal, R. N. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80008-8 · Cited by 306
EVIDENCE OF A TREATABLE ENDOCRINOPATHY IN INFERTILE MEN
PAVLOVICH, C. P., KING, P., GOLDSTEIN, M., & SCHLEGEL, P. N. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)66540-8 · Cited by 282
Gysler, M., March, C. M., Mishell, D. R., & Bailey, E. J. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46033-4 · Cited by 270
Sammour, A., Biljan, M. M., Tan, S. L., & Tulandi, T. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02323-8 · Cited by 238
Garcia, J., Jones, G. S., & Wentz, A. C. (1977) · Fertility and Sterility · doi:10.1016/s0015-0282(16)42670-1 · Cited by 233
Costello, M. F., & Eden, J. A. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04554-5 · Cited by 224 · cited 1×
“However, the authors found that adding metformin to CC resulted in an improved ovulation and pregnancy rate in both unselected and CC-resistant PCOS women [39].”
BackgroundIto, Y., Fisher, C. R., Conte, F. A., Grumbach, M. M., & Simpson, E. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11673 · Cited by 218
Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans
Kamat, A., Hinshelwood, M. M., Murry, B. A., & Mendelson, C. R. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00567-2 · Cited by 215
Ovulatory disorders in women with polycystic ovary syndrome
FRANKS, S., ADAMS, J., MASON, H., & POLSON, D. (1985) · Clinics in Obstetrics and Gynaecology · doi:10.1016/s0306-3356(21)00138-2 · Cited by 207
Mechanistic studies on aromatase and related CC bond cleaving P-450 enzymes
Akhtar, M., Njar, V. C. O., & Neville Wright, J. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90241-n · Cited by 193 · cited 1×
“Aromatase is a microsomal member of the cytochrome P450 haemoprotein-containing enzyme complex superfamily (P450arom, the product of the CYP19 gene) that catalyses the rate-limiting step in the production of oestrogens, that is, the conversion of androstenedione and testosterone via three hydroxylation steps to estron…”
BackgroundSonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth
Gonen, Y., & Casper, R. F. (1990) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137165 · Cited by 193
Self-citationSingle-dose pharmacokinetics of clomiphene citrate in normal volunteers
Mikkelson, T. J., Kroboth, P. D., Cameron, W. J., Dittert, L. W., Chungi, V., & Manberg, P. J. (1986) · Fertility and Sterility · doi:10.1016/s0015-0282(16)49574-9 · Cited by 170
INDUCTIOS OF OVULATIOK WITH CLOAIIPHESE CITRATE (CLOAIID)
KISTNER, R. W. (1965) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-196512000-00001 · Cited by 126
Randall, J. M., & Templeton, A. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54541-5 · Cited by 107
Yagel, S., Ben-Chetrit, A., Anteby, E., Zacut, D., Hochner-Celnikier, D., & Ron, M. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54772-4 · Cited by 97
Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue
Fang, Z., Yang, S., Gurates, B., Tamura, M., Simpson, E., Evans, D., & Bulun, S. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8683 · Cited by 91
The cellular effects of estrogens on neuroendocrine tissues
Naftolin, F., Maclusky, N. J., Leranth, C. Z., Sakamoto, H. S., & Garcia-Segura, L. M. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90093-3 · Cited by 86 · cited 1×
“There is evidence that both circulating oestrogen (produced by the ovaries) and locally produced oestrogen (produced in the brain) exert negative feedback on the release of gonadotrophins [72-76].”
BackgroundYang, S., Fang, Z., Suzuki, T., Sasano, H., Zhou, J., Gurates, B., Tamura, M., Ferrer, K., & Bulun, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8486 · Cited by 77
The Aromatase Cytochrome P-450 and Its Clinical Impact
Meinhardt, U., & Mullis, P.-E. (2002) · Hormone Research in Paediatrics · doi:10.1159/000058374 · Cited by 68
Intraovarian Regulation: The Proposed Role of Insulin‐like Growth Factorsa
ADASHI, E. Y. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb43847.x · Cited by 47
Aromatase inhibition for breast cancer treatment
Loünning, P. E. (1996) · Acta Oncologica · doi:10.3109/02841869609083966 · Cited by 39
Dranitsaris, G., Leung, P., Mather, J., & Oza, A. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200008000-00012 · Cited by 38 · cited 2×
“and letrozole are often referred to as aromatase inhibitors, whereas exemestane is called an aromatase inactivator [64-69].”
BackgroundInterface between Extra‐ and Intraovarian Factors in Polycystic Ovarian Syndrome
YEN, S. S. C., LAUGHLIN, G. A., & MORALES, A. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb43858.x · Cited by 36
Mitwally, M. F., & Casper, R. F. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01717-4 · Cited by 12
Self-citation
Cited by
Goswami, S. K. (2004) · Human Reproduction · doi:10.1093/humrep/deh359 · Cited by 372
“Recent studies demonstrated that addition of letrozole improved ovarian response to FSH in poor responders and reduced gonadotrophin dose required for COH in women with unexplained infertility ( Mitwally and Casper, 2002a; 2003a ).”
BackgroundClomiphene citrate—end of an era? a mini-review
Homburg, R. (2005) · Human Reproduction · doi:10.1093/humrep/dei042 · Cited by 331
Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study
Fatemi, H. M., Kolibianakis, E., Tournaye, H., Camus, M., Van Steirteghem, A., & Devroey, P. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62070-6 · Cited by 253
Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation
Mitwally, M. F., Biljan, M. M., & Casper, R. F. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.08.013 · Cited by 186
Self-citationFetal Safety of Letrozole and Clomiphene Citrate for Ovulation Induction
Forman, R., Gill, S., Moretti, M., Tulandi, T., Koren, G., & Casper, R. (2007) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32551-8 · Cited by 86
Self-citation
Metadata
- Authors
- Mitwally, M. F., & Casper, R. F.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2003-03
- Volume
- 12
- Issue
- 3
- Pages
- 353-371
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2152749001
- Cited by
- 120
- References
- 41
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.